Gentaur Vandortuzumab – Anti-STEAP1 Antibody

Gentaur Vandortuzumab – Anti-STEAP1 Antibody

Targets STEAP1, a transmembrane protein overexpressed in prostate and other cancers. Ideal for antibody–drug conjugate development.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days